2023;455 doi: 10.1016/j.cej.2022.140848
In combination with bupropion, naltrexone, a -opioid receptor antagonist, acts in a synergistic manner to stimulate weight loss by blocking the -endorphin-mediated inhibition of the POMC neuron [192]
Before anything becomes official, the FDA must review the meeting records, public comments and votes, then publish proposed rules and open them for feedback, a process that can take up to a year
The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]
& Sabatini, B
PubChem (NIH): Provides a comprehensive chemical summary, molecular weight verification, and safety data sheet references for *N-hexanoic-Tyr-Ile-(6) aminohexanoic amide*